Milton H. Werner's most recent trade in Inhibikase Therapeutics Inc was a trade of 45,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jan 2025 | 45,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jan 2025 | 35,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jan 2025 | 20,834 | 0 | - | - | Stock Option (Right to Buy) | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 20,834 | 20,834 | - | - | Stock Option (Right to Buy) | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jan 2025 | 16,667 | 0 | - | - | Stock Option (Right to Buy) | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 16,667 | 16,667 | - | - | Stock Option (Right to Buy) | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jan 2025 | 3,643 | 0 | - | - | Stock Option (Right to Buy) | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 3,643 | 3,643 | - | - | Stock Option (Right to Buy) | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jan 2025 | 3,643 | 0 | - | - | Stock Option (Right to Buy) | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 3,643 | 3,643 | - | - | Stock Option (Right to Buy) | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jan 2025 | 3,643 | 0 | - | - | Stock Option (Right to Buy) | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 3,643 | 3,643 | - | - | Stock Option (Right to Buy) | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jan 2025 | 3,643 | 0 | - | - | Stock Option (Right to Buy) | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 3,643 | 3,643 | - | - | Stock Option (Right to Buy) | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jan 2025 | 3,643 | 0 | - | - | Stock Option (Right to Buy) | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 3,643 | 3,643 | - | - | Stock Option (Right to Buy) | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 5,315,056 | 5,315,056 | - | - | Stock Option (Right to Buy) | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 4,059,744 | 4,059,744 | - | - | Stock Option (Right to Buy) | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 2,207,671 | 2,207,671 | - | - | Stock Option (Right to Buy) | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO, Ten Percent Owner | 01 Apr 2024 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | ||
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO, Ten Percent Owner | 01 Mar 2023 | 210,000 | 210,000 | - | - | Stock Option (right to buy) | ||
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO, Ten Percent Owner | 16 Aug 2022 | 5,000 | 5,335,433 | - | 0.8 | 4,000 | Common Stock | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO, Ten Percent Owner | 27 May 2022 | 5,000 | 5,330,433 | - | 1.0 | 4,880 | Common Stock | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO, Ten Percent Owner | 20 May 2022 | 10,000 | 5,325,433 | - | 0.6 | 6,000 | Common Stock | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO, Ten Percent Owner | 07 Mar 2022 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | ||
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO, Ten Percent Owner | 07 Mar 2022 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | ||
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO, Ten Percent Owner | 03 Jan 2022 | 21,853 | 5,315,433 | - | 2.0 | 44,143 | Common Stock | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO, Ten Percent Owner | 03 Jan 2022 | 21,853 | 0 | - | - | Stock Option (right to buy) | ||
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO, Ten Percent Owner | 17 Nov 2021 | 17,569 | 23,589 | - | 2.0 | 34,787 | Common Stock | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO, Ten Percent Owner | 17 Nov 2021 | 3,186 | 23,589 | - | 2.0 | 6,245 | Common Stock | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO, Ten Percent Owner | 17 Nov 2021 | 1,334 | 23,589 | - | 1.9 | 2,588 | Common Stock | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO, Ten Percent Owner | 17 Nov 2021 | 1,100 | 23,589 | - | 2.0 | 2,167 | Common Stock | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO, Ten Percent Owner | 17 Nov 2021 | 400 | 23,589 | - | 1.9 | 772 | Common Stock | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO, Ten Percent Owner | 17 Aug 2021 | 21,853 | 5,293,580 | - | 2.0 | 44,143 | Common Stock | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO, Ten Percent Owner | 17 Aug 2021 | 21,853 | 0 | - | - | Stock Option (right to buy) | ||
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO, Ten Percent Owner | 14 May 2021 | 43,707 | 0 | - | - | Stock Option (right to buy) | ||
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO, Ten Percent Owner | 14 May 2021 | 43,707 | 5,288,645 | - | 0.4 | 16,609 | Common Stock | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO, Ten Percent Owner | 14 May 2021 | 16,918 | 5,271,727 | - | 4.6 | 77,654 | Common Stock | |
| Inhibikase Therapeutics Inc | Milton H. Werner | Director, President and CEO, Ten Percent Owner | 22 Dec 2020 | 100,000 | 100,000 | - | - | Stock Option (right to buy) |